Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 21.40
0.00 (0.00%)
Last updated: Feb 20, 2026, 9:26 AM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 123.43 million as of February 20, 2026. Its market cap has increased by 4.35% in one year.
Market Cap
123.43M
Enterprise Value
270.94M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.71
Stock Price
21.40
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 123.43M, a decrease of -48.67%. That is a compound annual growth rate of -15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 123.43M | -13.36% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.02B |
| Basilea Pharmaceutica AG | 663.56M |
| Newron Pharmaceuticals | 420.31M |
| Santhera Pharmaceuticals Holding AG | 237.86M |
| BioVersys AG | 137.43M |
| Molecular Partners AG | 135.38M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.67M |